![Maria Fardis](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Maria Fardis
Direktor/Vorstandsmitglied bei
CRISPR THERAPEUTICS AG
Vermögen: - $ am 30.06.2026
Profil
Derzeit hat Maria Fardis die Position des President, Chief Executive Officer & Director bei Iovance Biotherapeutics, Inc. inne. Sie ist auch im Vorstand der Alliance for Regenerative Medicine und Kartos Therapeutics, Inc. In der Vergangenheit war sie Chief Operating Officer bei Acerta Pharma LLC, Associate Director-Project & Portfolio Management bei Gilead Sciences, Inc. sowie Chief Operating Officer von Acerta Pharma BV und Chief Oncology Operations & Alliances bei Pharmacyclics LLC. Dr. Fardis erhielt einen Doktortitel von der University of California, Berkeley, einen MBA von der Golden Gate University und einen Bachelor-Abschluss von der University of Illinois in Urbana-Champaign.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 05.06.2026 | 0 ( -.--% ) | - $ | 30.06.2026 |
Aktuelle Nachrichten zu Maria Fardis
Aktive Positionen von Maria Fardis
| Unternehmen | Position | Beginn |
|---|---|---|
| CRISPR THERAPEUTICS AG | Direktor/Vorstandsmitglied | 09.06.2022 |
Lassen Therapeutics 1, Inc.
 Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics | Vorstandsvorsitzender | 01.04.2023 |
Quanta Therapeutics, Inc.
 Quanta Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnologies | Direktor/Vorstandsmitglied | - |
Lassen Therapeutics LLC
 Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Vorstandsvorsitzender | 04.05.2023 |
Obsidian Therapeutics, Inc.
 Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Vorsitzender | 19.01.2022 |
Frazier Management LLC
 Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Private Equity Investor | 22.09.2021 |
Kartos Therapeutics, Inc.
 Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company that develops novel and targeted therapeutics | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Maria Fardis
| Unternehmen | Position | Ende |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Vorstandsvorsitzender | 18.06.2021 |
Acerta Pharma LLC
 Acerta Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in drug development | Geschäftsführer | 01.03.2016 |
| ░░░░░░ ░░░░░░ ░░ | ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Ausbildung von Maria Fardis
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
90
Beziehungen ersten Grades
16
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 16 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Pharmacyclics LLC
 Pharmacyclics LLC Pharmaceuticals: MajorHealth Technology Manufactures drugs intended to treat cancer and atherosclerosis | Health Technology |
Frazier Management LLC
Frazier Management LLC Investment ManagersFinance Frazier Healthcare Partners invests in companies located in the United States. The firm focuses on pharmaceuticals, healthcare services and medical products & distribution sectors. It provides financing for growth and transformation transactions. | Finance |
Golden Gate University
 Golden Gate University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services Promotes legislative, regulatory and reimbursement initiatives for regenerative medicine | Health Services |
Acerta Pharma BV
 Acerta Pharma BV Pharmaceuticals: GenericHealth Technology Develops drugs for oncology and autoimmune diseases | Health Technology |
CRISPR Therapeutics AG
 CRISPR Therapeutics AG BiotechnologyHealth Technology Develops gene-based medicines | Health Technology |
Obsidian Therapeutics, Inc.
Obsidian Therapeutics, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company that develops TIL cell therapies for the treatment of patients with solid tumors | Health Technology |
University of Illinois At Urbana–Champaign
 University of Illinois At Urbana–Champaign Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Quanta Therapeutics, Inc.
Quanta Therapeutics, Inc. BiotechnologyHealth Technology Develops biotechnologies | Health Technology |
Kartos Therapeutics, Inc.
Kartos Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical stage biopharmaceutical company that develops novel and targeted therapeutics | Health Technology |
Lassen Therapeutics LLC
Lassen Therapeutics LLC Miscellaneous Commercial ServicesCommercial Services Operates as a clinical stage company that develops and manufactures therapeutic antibody products | Commercial Services |
Lassen Therapeutics 1, Inc.
Lassen Therapeutics 1, Inc. BiotechnologyHealth Technology Develops novel and best-in-class biotherapeutics | Health Technology |
Acerta Pharma LLC
Acerta Pharma LLC Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that specializes in drug development | Health Technology |
Wählen Sie MarketScreener 
